OOIR: Observatory of International Research

Papers

(The TQCC of Personalized Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women	57
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward	28
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness	18
Pharmacogenomics education in China and the United States: advancing personalized medicine	17
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population	16
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients	14
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls	12
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension	11
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis	11
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease	9
Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations	9
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?	8
Precision acute medical care through “-omic” analyses: a scoping review	8
Personalized approach in arrhythmology by genetic-based data: a case report	8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis	8
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	8
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer	8
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study	7
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar	7
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation	7
Welcome to the 19th Volume of Personalized Medicine	7
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children	7
Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities	7
Development of Competency-based Online Genomic Medicine Training (COGENT)	6
Role of precision nutrition in improving military performance	6

Looking Back Over 2023 and Welcome to the 21 ^st Issue of Personalized Medicine	6
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups	6
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	6
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam	6
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System	5
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection	5
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice	5
The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer	5
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	5
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead	5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head	5
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation	5
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus	4
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	4
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment	4
SKA3 , negatively regulated by miR-128-3p , promotes the progression of non-small-cell lung cancer	4
A GRIN3A Polymorphism may be Associated with Glucocorticoid-Induced Symptomatic Osteonecrosis in Children with Acute Lymphoblastic Leukemia	4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device	4
Genomics and the early diagnosis of lung cancer	4
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation	4
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients	4
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis	4
Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives	4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population	4
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines	4
Global harmonization in advanced therapeutics: balancing innovation, safety, and access	4